Nancy Brown Archives
Vanderbilt study finds erectile dysfunction drug may benefit patients at risk for diabetes
Nov. 18, 2015—The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported. Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and increased blood flow. Sildenafil is used to treat erectile dysfunction and pulmonary arterial...
Photo: Discovery trio
Oct. 1, 2015—Vanderbilt’s Thomas Wang, M.D., left, Nancy Brown, M.D., and David Bader, Ph.D., explored the human determinants of cardiovascular disease and treatment at last week’s Flexner Discovery Lecture.
Vanderbilt researchers to discuss heart disease, treatment at lecture
Sep. 17, 2015—Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.
Vanderbilt’s Brown, Crowe elected to IOM
Oct. 21, 2014— Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization announced this week. With more than 1,900 active members and foreign associates, the IOM...
Aronoff to lead Division of Infectious Diseases
Nov. 14, 2013—David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.
Pollen counts boost risk of rare drug reaction: study
Jul. 25, 2013—High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found.
Clinical Pharmacology celebrates 50th anniversary
Jun. 13, 2013—Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
Better blood pressure-reducing drugs?
Apr. 30, 2012—A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
Meds’ benefits differ in dialysis patients
Jan. 5, 2012—About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to selecting medication for heart disease...
Initiative to help ‘translate’ diabetes research advances
Oct. 21, 2011—The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.
Predicting hospital readmission is risky business: study
Oct. 18, 2011—Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.
